Dr. Zhang Huibiao, M.D., PhD, and Master’s Supervisor, Chief Physician, Member of the Thoracic Surgery Branch and concurrently Chair of the Enhanced Recovery After Surgery (ERAS) Working Group of the Shanghai Medical Association, Member of the Lung Cancer Committee of the Shanghai Anti-Cancer Association, Member of the Thoracic Surgery Committee of the Shanghai Society of Integrated Traditional and Western Medicine, Member of the Clinical Research Committee for Thoracic Oncology of the Shanghai Research-oriented Hospitals Association, Young Member of the Chemotherapy Professional Committee of the China Medical Education Association, Young Member of the Cancer Rehabilitation and Palliative Care Professional Committee of the Shanghai Anti-Cancer Association, and Secretary of the Fudan University Thoracic Oncology Research Institute. With over 20 years of experience in thoracic surgery, he specializes in the diagnosis, treatment, and comprehensive management of pulmonary ground-glass opacities; he is skilled in minimally invasive surgery for thoracic diseases such as lung cancer, esophageal cancer, and mediastinal tumors; he has particular expertise in minimally invasive surgery without general anesthesia, intubation-free management during surgery, and enhanced recovery after surgery; he also possesses extensive experience in the comprehensive treatment of thoracic tumors. He was awarded third place in the Lung Resection (Expert Group) category at the First China Thoracic Surgery Standardization and Innovation Summit (Eastern Region); recognized as an Outstanding Resident Training Instructor in Shanghai; and honored as an Outstanding Teaching Instructor at Fudan University. He has led multiple research projects, with findings published in over 10 articles in renowned domestic and international journals (with a combined impact factor exceeding 70).